semaglutide compound california Compounded Online Prescription for Weight Loss FDA Warns on Certain Forms

A 17% Reduction in Overall Cancer Risk A landmark study published in JAMA Oncology (Dai H et al., August 2025), drawing on data from 14 health systems encompassing approximately 20 million patients, found that adults with obesity who were prescribed GLP-1 receptor agonists had a 17% lower risk of developing cancer compared to carefully matched non-users

P.BucheggerF.MeierC

Find your stack in 60 seconds The honest verdict L-carnitine has a real, well-understood physiological role in energy metabolism it's the shuttle that moves fatty acids into your cells' mitochondria to be used for fuel

Three further Phase 3 trial results in the TRIUMPH programme are due before the end of 2026: TRIUMPH-2 in obesity with type 2 diabetes, TRIUMPH-3 in obesity with established cardiovascular disease (with further safety information relevant to higher-risk populations), and obstructive sleep apnoea